Heart disease and rheumatoid arthritis: Understanding the risks

Annals of the Rheumatic Diseases

Volumn 69, Issue SUPPL. 1, 2010, Pages

  Gabriel, S E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

BODY MASS; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; HEART DISEASE; HEART FAILURE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; ISCHEMIC HEART DISEASE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SMOKING HABIT; COMORBIDITY; DYSLIPIDEMIA; OUTCOME ASSESSMENT; POPULATION RISK; RISK ASSESSMENT; RISK FACTOR;

ARTHRITIS, RHEUMATOID; BODY MASS INDEX; CARDIOVASCULAR DISEASES; HEART RATE; HUMANS; LIPIDS; RISK FACTORS;

EID: 75749092567     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2009.119404     Document Type: Review

References (16)

1. Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum 2006;36:182- 8.
2. Gonzalez A, Maradit Kremers H, Crowson CS, et al. The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum 2007;56:3583-7.
3. Gonzalez A, Kremers HM, Crowson CS, et al. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in nonrheumatoid arthritis patients? Ann Rheum Dis 2008;67:64-9.
4. Solomon DH, Curhan GC, Rimm EB, et al. Cardiovascular risk factors in women with and without rheumatoid arthritis. Arthritis Rheum 2004;50:3444-9.
5. Maradit Kremers HM, Nicola PJ, Crowson CS, et al. Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis. Arthritis Rheum 2004;50:3450-7.
6. Escalante A, Haas RW, del Rincon I. Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch Intern Med 2005;165:1624-9.
7. Myasoedova E, Maradit Kremers H, Fitz-Gibbon P, et al. Lipid profile improves with the onset of rheumatoid arthritis. Ann Rheum Dis 2009;68(Suppl3):78.
8. Maradit Kremers H, Nicola PJ, Crowson CS, et al. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005;52:722-32.
9. Maradit Kremers H, Nicola PJ, Crowson CS, et al. Raised erythrocyte sedimentation rate signals heart failure in patients with rheumatoid arthritis. Ann Rheum Dis 2007;66:76-80.
10. Liang KL, Maradit Kremers H, Crowson CS, et al. Autoantibodies and the risk of cardiovascular events. J Rheumatol 2009; in press.
11. Crowson CS, Nicola PJ, Maradit Kremers H, et al. How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? Arthritis Rheum 2005;52:3039-44.
12. Maradit Kremers H, Crowson CS, Therneau TM, et al. High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a populationbased cohort study. Arthritis Rheum 2008;58:2268-74.
13. Weiner DE, Tighiouart H, Elsayed EF, et al. The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol 2007;50:217-24.
14. McEwan P, Williams JE, Griffiths JD, et al. Evaluating the performance of the Framingham risk equations in a population with diabetes. Diabet Med 2004;21:318-23.
15. Zgibor JC, Piatt GA, Ruppert K, et al. Deficiencies of cardiovascular risk prediction models for type 1 diabetes. Diabetes Care 2006;29:1860-5.
16. Ruppert K, Roberts MS, Orchard TJ, Zgibor JC. Cardiovascular disease risk prediction in type 1 diabetes: accounting for the differences. Diabetes Res Clin Pract 2007;78:234-7.